Fingerprint
Dive into the research topics where Rob de Knegt is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Diabetes Mellitus is a Risk Factor for Hepatic Encephalopathy Following Transjugular Intrahepatic Portosystemic Shunt
Spaan, M., Werner, E., Dijkstra, W., Erler, N. E., Bijdevaate, D., Murad, S. D., Sonneveld, M. J., den Hoed, C. M., van Eldere, A., Sprengers, D. S., Brouwer, W. P., de Knegt, R. J., Janssen, H. L. A., Pieterman, K., Coenen, S., Maan, R. & van der Meer, A. J., 28 Nov 2025, (E-pub ahead of print) In: Alimentary Pharmacology and Therapeutics.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile4 Citations (Scopus)3 Downloads (Pure) -
The global prevalence and impact of steatotic liver disease and viral infections: A systematic review and meta-analysis
Li, J., Zhou, J., Li, P., Wang, Y., Ridderhof, N., Al-Tawfiq, J. A., Brouwer, W. P., Chen, K., De Knegt, R. J., Peppelenbosch, M. P., Hansen, B. E., Engel, M. F. M., Zheng, M. H., Memish, Z. A., Eslam, M., Janssen, H. L. A., Pan, Q. & Ayada, I., May 2025, In: Hepatology Communications. 9, 5, e0689.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile4 Citations (Scopus)27 Downloads (Pure) -
The Association Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Change in Liver Stiffness in Patients With Chronic Hepatitis B
Patmore, L. A., van Eekhout, K., Koc, Ö. M., de Knegt, R. J., Janssen, H. L. A., Brouwer, W. P., Kramer, M., Honkoop, P., de Bruijne, J., Boland, G. J., Postma, D. F., Blokzijl, H., de Man, R. A., Takkenberg, R. B. & Sonneveld, M. J., Mar 2025, In: Liver International. 45, 3, e70042.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile4 Citations (Scopus)36 Downloads (Pure) -
Pharmacological treatment options for metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus: A systematic review
Konings, L. A. M., Miguelañez-Matute, L., Boeren, A. M. P., van de Luitgaarden, I. A. T., Dirksmeier, F., de Knegt, R. J., Tushuizen, M. E., Grobbee, D. E., Holleboom, A. G. & Cabezas, M. C., 12 Feb 2025, (E-pub ahead of print) In: European Journal of Clinical Investigation. 55, 4, e70003.Research output: Contribution to journal › Review article › Academic › peer-review
Open AccessFile15 Citations (Scopus)82 Downloads (Pure) -
Editorial: Navigating the Beta-Blocker Dilemma in Advanced Liver Cirrhosis-When Is the Right Time to Discontinue?
Alferink, L. J. M. & de Knegt, R. J., Jan 2025, In: Alimentary Pharmacology & Therapeutics. 61, 1, p. 192-193 2 p.Research output: Contribution to journal › Editorial › Academic › peer-review
Open AccessFile1 Citation (Scopus)35 Downloads (Pure)